FIL Limited Form 8.3 - ALLERGAN PLC (5045G)
20 Novembro 2015 - 1:18PM
UK Regulatory
TIDMPFZ TIDMIRSH
RNS Number : 5045G
FIL Limited
20 November 2015
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT,
1997,
TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note FMR LLC and/or one or more of its direct
1) or indirect subsidiaries
And
FIL Limited and/or one or more of its direct
and indirect subsidiaries
Company dealt in ALLERGAN PLC
----------------------------------------------
Class of relevant security Ordinary Shares and preferred convertible
to which the dealings being stock
disclosed relate (Note 2)
----------------------------------------------
Date of dealing 19-November-15
----------------------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security
dealt in (Note 3)
Ordinary Shares Long Short
Number (%) Number (%)
----------------- -----------
(1) Relevant securities 15,903,452 4.03%
----------------- -----------
(2) Derivatives (other than
options)
----------------- -----------
(3) Options and agreements
to purchase/sell
----------------- -----------
Total 15,903,452 4.03%
----------------- -----------
The above position includes a transfer out of 8 shares.
Preferred Convertible Stock Long Short
Number (%) Number (%)
-------------- -----------
(1) Relevant securities 258,334 5.01%
-------------- -----------
(2) Derivatives (other than
options)
-------------- -----------
(3) Options and agreements
to purchase/sell
-------------- -----------
Total 258,334 5.01%
-------------- -----------
(b) Interests and short positions in relevant securities of the company, other than the
class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
----------- -----------
(1) Relevant securities
----------- -----------
(2) Derivatives (other than
options)
----------- -----------
(3) Options and agreements
to purchase/sell
----------- -----------
Total
----------- -----------
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of securities Price per unit
Buy (preferred convertible stock 2.8345 conversion factor) 4,500 1,019.256 USD/ Share
--------------------- ---------------------
Buy 1 302.5 USD/ Share
--------------------- ---------------------
Buy 1,674 302.6498 USD/ Share
--------------------- ---------------------
Buy 2,276 302.8108 USD/ Share
--------------------- ---------------------
Buy 150 302.6467 USD/ Share
--------------------- ---------------------
Buy 5,900 302.93 USD/ Share
--------------------- ---------------------
Buy 3,800 306.7404 USD/ Share
--------------------- ---------------------
Buy 500 306.472 USD/ Share
--------------------- ---------------------
Buy 1,200 308.075 USD/ Share
--------------------- ---------------------
Buy 800 306.31 USD/ Share
--------------------- ---------------------
Buy 625 306.06 USD/ Share
--------------------- ---------------------
Buy 478 307.82 USD/ Share
--------------------- ---------------------
Buy 45 304.83 USD/ Share
--------------------- ---------------------
Buy 30 306.67 USD/ Share
--------------------- ---------------------
Buy 62 306.055 USD/ Share
--------------------- ---------------------
Buy 20 309.70 USD/ Share
--------------------- ---------------------
Buy 9 306.86 USD/ Share
--------------------- ---------------------
Buy 21 310.78 USD/ Share
--------------------- ---------------------
Sale 22 304.93 USD/ Share
--------------------- ---------------------
Sale 23 307.72 USD/ Share
--------------------- ---------------------
Sale 6 304.888 USD/ Share
--------------------- ---------------------
Sale 2 304.925 USD/ Share
--------------------- ---------------------
Sale 3 304.88 USD/ Share
--------------------- ---------------------
Sale 2 309.55 USD/ Share
--------------------- ---------------------
Sale 1 302.81 USD/ Share
--------------------- ---------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of securities Price per unit (Note
e.g. CFD (Note 6) (Note 7) 5)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of securities Exercise Type, e.g. Expiry Option money
e.g. call option selling, to which the price American, date paid/received
purchasing, option relates European per unit
varying etc. (Note 7) etc. (Note 5)
(ii) Exercising
Product name, e.g. call Number of securities Exercise price per unit
option (Note 5)
(MORE TO FOLLOW) Dow Jones Newswires
November 20, 2015 10:18 ET (15:18 GMT)
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
